IMAX CORP (IMAX) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:IMAX - CA45245E1097 - Common Stock
37.45 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to IMAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.78. This target is 16.89% above the current price.
IMAX was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about IMAX.
In the previous month the buy percentage consensus was at a similar level.
IMAX was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-12-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-10-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-24 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-24 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-24 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-14 | Roth Capital | Maintains | Buy -> Buy |
| 2025-10-09 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-10-09 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-22 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-09-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-25 | Benchmark | Maintains | Buy -> Buy |
| 2025-07-25 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-25 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-07-11 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-07-09 | Roth Capital | Reiterate | Buy -> Buy |
| 2025-06-16 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-06-13 | Roth Capital | Maintains | Buy -> Buy |
| 2025-04-25 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-04-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-24 | Rosenblatt | Maintains | Buy -> Buy |
IMAX CORP / IMAX FAQ
Can you provide the average price target for IMAX CORP stock?
18 analysts have analysed IMAX and the average price target is 43.78 USD. This implies a price increase of 16.89% is expected in the next year compared to the current price of 37.45.
What is the consensus rating for IMAX stock?
The consensus rating for IMAX CORP (IMAX) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.